These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6097492)

  • 1. A new strain of Epstein-Barr virus derived from nasopharyngeal carcinoma hybrid cells.
    Takimoto T; Ogura H; Sato H; Hatano M
    Gan; 1984 Nov; 75(11):947-9. PubMed ID: 6097492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of transforming and early antigen-inducing Epstein-Barr virus from nasopharyngeal carcinoma hybrid cells (NPC-KT).
    Takimoto T; Ogura H; Sato H; Umeda R; Hatano M
    J Natl Cancer Inst; 1985 Jan; 74(1):57-60. PubMed ID: 2982054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of Epstein-Barr virus derived from a nasopharyngeal carcinoma that has transforming and lytic properties.
    Sato H; Takimoto T; Ogura H; Tanaka J; Hatano M; Glaser R
    J Natl Cancer Inst; 1986 Jun; 76(6):1019-24. PubMed ID: 3012175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus in somatic cell hybrids between mouse cells and human nasopharyngeal carcinoma cells.
    Steplewski Z; Koprowski H; Andersson-Anvret M; Klein G
    J Cell Physiol; 1978 Oct; 97(1):1-8. PubMed ID: 213442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumorigenicity of nasopharyngeal carcinoma hybrid cell line.
    Takimoto T; Ogura H; Ohno S; Umeda R; Hatano M
    J Natl Cancer Inst; 1984 Sep; 73(3):711-5. PubMed ID: 6088881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-regulation studies on somatic-cell hybrids derived from the fusion of Burkitt's lymphoma and nasopharyngeal carcinoma cells with human or mouse partners.
    Klein G
    IARC Sci Publ (1971); 1978; (20):369-76. PubMed ID: 215519
    [No Abstract]   [Full Text] [Related]  

  • 7. Epstein-Barr virus-determined nuclear antigen in malignant epithelial cells of nasopharyngeal carcinoma.
    Suzuki T; Katano A; Oboshi S; Sairenji T; Hinuma Y
    Gan; 1978 Feb; 69(1):133-8. PubMed ID: 205477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytopathic effects induced by Epstein-Barr virus replication in epithelial nasopharyngeal carcinoma hybrid cells.
    Sato H; Takimoto T; Tanaka S; Ogura H; Shiraishi K; Tanaka J
    J Virol; 1989 Aug; 63(8):3555-9. PubMed ID: 2545926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rescue of a biologically active Epstein-Barr virus from nonproducer cells.
    Takimoto T; Sato H; Ogura H; Glaser R
    Cancer Res; 1986 Apr; 46(4 Pt 2):2085-7. PubMed ID: 3004720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Epstein-Barr virus genome in nude-mouse-growth nasopharyngeal carcinoma cells.
    Yang CS; Hsu YV; Chan TK; Yeh TS; Chu CT; Tu SM
    Taiwan Yi Xue Hui Za Zhi; 1982 Jul; 81(7):882-91. PubMed ID: 6292325
    [No Abstract]   [Full Text] [Related]  

  • 11. Further studies on antibodies to early antigens induced by Epstein-Barr virus in nasopharyngeal carcinoma patients.
    Ida S; Hinuma Y; Chu CT; Chiou JF; Lai JG
    Gan; 1973 Dec; 64(6):545-53. PubMed ID: 4360581
    [No Abstract]   [Full Text] [Related]  

  • 12. Epstein-Barr virus activation of human epithelial-nasopharyngeal carcinoma hybrid cells.
    Takimoto T; Umeda R; Ogura H; Hatano M
    Am J Otolaryngol; 1984; 5(1):1-6. PubMed ID: 6099983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus lytic cycle spreads via cell fusion in a nasopharyngeal carcinoma hybrid cell line.
    Yoshizaki T; Takimoto T; Takeshita H; Tanaka S; Furukawa M; Seiki M; Sato H
    Laryngoscope; 1994 Jan; 104(1 Pt 1):91-4. PubMed ID: 8295464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transfection of human nasopharyngeal epithelial cells with Epstein-Barr virus DNA derived from nasopharyngeal carcinoma].
    Takimoto T; Miyazaki T; Ishikawa S; Iwawaki J; Tanaka S; Masuda K
    Nihon Jibiinkoka Gakkai Kaiho; 1987 Sep; 90(9):1334-8. PubMed ID: 2831323
    [No Abstract]   [Full Text] [Related]  

  • 15. The sero-epidemiology of Epstein-Barr virus.
    Henle W; Henle G
    Adv Pathobiol; 1976; (5):5-17. PubMed ID: 220858
    [No Abstract]   [Full Text] [Related]  

  • 16. Epstein-Barr virus serology in the control of nasopharyngeal carcinoma.
    Levine PH; Connelly RR; Milman G; Easton J
    Cancer Detect Prev; 1988; 12(1-6):357-62. PubMed ID: 2846170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus in nontumorigenic and tumorigenic nasopharyngeal carcinoma (NPC) somatic cell hybrids.
    Staczek J; Steplewski Z; Weinmann R; Klein G; Koprowski H
    J Cell Physiol; 1981 Jun; 107(3):391-8. PubMed ID: 6265479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nasopharyngeal carcinoma and the Epstein-Barr virus].
    Boger-Goren S; Gotlieb-Stematsky T
    Harefuah; 1985 May; 108(10):514-6. PubMed ID: 2995214
    [No Abstract]   [Full Text] [Related]  

  • 19. [Transmission of Epstein-Barr virus specific antigen associated with cell fusion activity].
    Furukawa M; Komori T; Ishiguro H; Umeda R
    Nihon Jibiinkoka Gakkai Kaiho; 1985 Jan; 88(1):20-4. PubMed ID: 2987466
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inhibitory effect of retinoids on Epstein-Barr virus induction in Raji cells].
    Zeng Y; Zhou HM; Xu JP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Aug; 4(4):251-3. PubMed ID: 6295650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.